Neuronetics STIM Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Clinical Services | $21.53M+15.4% | —— | —— | —— | $18.66M+1,579% | |
| Medical Device | $12.93M-2.9% | —— | $37.3M+101% | $38.11M+132% | $13.32M-23.5% | |
| Gross Profit by Business | ||||||
| Clinical Services | $6.09M+9.2% | —— | —— | —— | $5.57M+1,709% | |
| Medical Device | $10.07M-1.0% | $684K-95.0% | $17.11M+22.2% | $17.76M+45.8% | $10.17M-22.3% | |
| Operating Income by Business | ||||||
| Clinical Services | -$1.86M+23.1% | —— | —— | —— | -$2.41M-2,744% | |
| Medical Device | $1.34M+1,088% | $29.64M— | -$7.32M+5.3% | -$8.06M+5.3% | -$136K+98.0% | |
| Selling General And Administrative Expense by Business | ||||||
| Clinical Services | $7.88M-0.6% | —— | —— | —— | $7.93M+3,616% | |
| Medical Device | $7.42M-15.1% | —— | —— | —— | $8.74M-22.0% | |
| Research And Development Expense by Business | ||||||
| Clinical Services | $60K+17.6% | —— | —— | —— | $51K+1,469% | |
| Medical Device | $1.31M-16.6% | $5.32M-49.9% | $321K-55.4% | $458K-26.5% | $1.57M+95.6% | |
| Cost of Goods Sold by Business | ||||||
| Clinical Services | $15.44M+18.0% | —— | —— | —— | $13.09M+1,529% | |
| Medical Device | $2.86M-9.3% | —— | $20.19M+346% | $20.35M+376% | $3.15M-27.2% | |
| Revenue by Product | ||||||
| Clinic Revenue | $21.53M+15.4% | $23.49M+2,013% | $21.81M+1,862% | $23.02M+1,972% | $18.66M+1,579% | |
| Neuro Star Advanced Therapy System | $3.25M+7.9% | $4.92M+18.0% | $3.96M-9.1% | $3.65M-8.9% | $3.01M-15.6% | |
| Service | $21.53M+15.4% | —— | —— | —— | $18.66M+1,579% | |
| Treatment Sessions | $9.25M-5.3% | $12.84M-1.8% | $10.76M-19.8% | $11.05M-6.3% | $9.76M-25.8% | |
| Concentration Risk % by Product | ||||||
| Clinic Revenue | 63%+4.0pp | —— | 60%+58.5pp | 61%+59.5pp | 59%+57.5pp | |
| Neuro Star Advanced Therapy System | 29%-13.0pp | 3%+2.0pp | 53%-10.0pp | 45%+20.0pp | 42%-19.0pp | |
| Treatment Sessions | 81%+19.0pp | 3%— | 49%-40.0pp | 91%-24.0pp | 62%-43.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Neuronetics break its business down?
- Neuronetics (STIM) reports revenue by business across 2 parts — Clinical Services and Medical Device. Each is extracted from the segment footnotes and tracked over time.
- Where does Neuronetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Neuronetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
